|
- 2018
Use of Idarucizumab for dabigatran reversal: Emergency department experience in two cases with subdural haematomaDOI: 10.1016/j.tcr.2017.12.003 Keywords: Idarucizumab, Dabigatran, Intracranial haemorrhage, Wounds and injuries, Emergency department Abstract: Idarucizumab is the first effective humanized monoclonal antibody fragment developed specifically as a reversal agent for dabigatran, a Direct Oral Anticoagulant. Despite recent trials demonstrating reversal of clinically relevant bleeding, there is a paucity of data on use outside the trial setting. This manuscript describes the use of Idarucizumab to reverse dabigatran in two patients presenting to the emergency department of a major tertiary hospital with acute traumatic subdural haematomas (SDH)
|